Related Experiment Video
Updated: Oct 12, 2025

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
Published on: November 4, 2016
Efficacy Profiles of Antimicrobials Evaluated against Staphylococcus Species Isolated from Canine Clinical Specimens
Daniel Nenene Qekwana1, Agricola Odoi2, James Wabwire Oguttu3
1Section of Veterinary Public Health, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Pretoria 0110, South Africa.
Abstract:
Cross-resistance occurs between antimicrobials with either similar mechanisms of action and/or similar chemical structures, or even between unrelated antimicrobials. This study employed a multivariate approach to investigate the associations between the efficacy profile of antimicrobials and the clustering of eleven different antimicrobial agents based on their efficacy profile. Records of the susceptibility of 382 confirmed Staphylococcus species isolates against 15 antimicrobials based on the disc diffusion method were included in this study. Tetrachoric correlation coefficients were computed to assess the correlations of antimicrobial efficacy profiles against Staphylococcus aureus. Principal components analysis and factor analysis were used to assess the clustering of antimicrobial susceptibility profiles. Strong correlations were observed among aminoglycosides, penicillins, fluroquinolones, and lincosamides. Three main factors were extracted, with Factor 1 dominated by the susceptibility profile of enrofloxacin (factor loading (FL) = 0.859), gentamicin (FL = 0.898), tylosin (FL = 0.801), and ampicillin (FL = -0.813). Factor 2, on the other hand, was dominated by the susceptibility profile of clindamycin (FL = 0.927) and lincomycin-spectinomycin (FL = 0.848) and co-trimazole (FL = -0.693). Lastly, Factor 3 was dominated by the susceptibility profile of amoxicillin-clavulanic acid (FL = 0.848) and cephalothin (FL = 0.824). Antimicrobials belonging to the same category or class of antimicrobial, tended to exhibit similar efficacy profiles, therefore, laboratories must choose only one of the antimicrobials in each group to help reduce the cost of antimicrobial susceptibility tests.
Insights
Antimicrobial efficacy profiles cluster by drug class, revealing cross-resistance patterns. Laboratories can reduce antimicrobial susceptibility testing costs by selecting one agent per class.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Cross-resistance among antimicrobials, whether related or unrelated, poses a significant challenge in infectious disease management.
- Understanding antimicrobial efficacy profiles and their associations is crucial for optimizing treatment strategies and diagnostic testing.
Purpose of the Study:
- To investigate the associations between antimicrobial efficacy profiles and the clustering of eleven antimicrobial agents.
- To analyze antimicrobial susceptibility profiles in *Staphylococcus* species using a multivariate approach.
Main Methods:
- A multivariate approach was employed, analyzing susceptibility data from 382 *Staphylococcus* isolates against 15 antimicrobials via disc diffusion.
- Tetrachoric correlation coefficients were computed to assess correlations in antimicrobial efficacy profiles.
- Principal components analysis and factor analysis were utilized to determine the clustering of antimicrobial susceptibility profiles.
Main Results:
- Strong correlations in efficacy profiles were observed among aminoglycosides, penicillins, fluoroquinolones, and lincosamides.
- Three main factors emerged, with Factor 1 linked to enrofloxacin, gentamicin, tylosin, and ampicillin; Factor 2 to clindamycin, lincomycin-spectinomycin, and co-trimoxazole; and Factor 3 to amoxicillin-clavulanic acid and cephalothin.
- Antimicrobials within the same class generally exhibited similar efficacy profiles.
Conclusions:
- Antimicrobial agents tend to cluster based on their efficacy profiles, often aligning with their respective drug classes.
- Laboratories can optimize antimicrobial susceptibility testing by selecting a single representative antimicrobial agent from each identified efficacy group, thereby reducing costs.
Related Concept Videos
Antimicrobial Effectiveness
Combined Effects of Drugs: Synergism
Such synergistic combinations...

